A detailed history of Thematics Asset Management transactions in Exact Sciences Corp stock. As of the latest transaction made, Thematics Asset Management holds 83,216 shares of EXAS stock, worth $5.67 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
83,216
Previous 68,019 22.34%
Holding current value
$5.67 Million
Previous $4.7 Million 25.16%
% of portfolio
0.15%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $628,092 - $1.13 Million
15,197 Added 22.34%
83,216 $3.52 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $530,175 - $695,060
9,422 Added 16.08%
68,019 $4.7 Million
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $930,667 - $1.19 Million
15,758 Added 36.78%
58,597 $4.34 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $325,216 - $488,465
-4,932 Reduced 10.32%
42,839 $2.92 Million
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $1.45 Million - $2.54 Million
47,771 New
47,771 $0

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Thematics Asset Management Portfolio

Follow Thematics Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thematics Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Thematics Asset Management with notifications on news.